US Sues Gilead, Alleging PrEP Drugs Infringe on HHS Patents
On behalf of the Department of Health and Human Services (HHS), the United States recently sued Gilead Sciences and Gilead Sciences Ireland over their preexposure prophylaxis (PrEP) drugs.
On behalf of the Department of Health and Human Services (HHS), the United States recently sued Gilead Sciences and Gilead Sciences Ireland over their preexposure prophylaxis (PrEP) drugs.
This case series reports ophthalmic complications associated with the antidiabetic drugs semaglutide and tirzepatide.
This Viewpoint discusses the importance of federal funding of biomedical research from the National Institutes of Health to scientific discovery, advancements in individual and public…
This cohort study evaluated the association of convalescent plasma treatment with 30-day mortality in hospitalized adults with hematologic cancers and COVID-19.
This Viewpoint highlights 10 categories of recommendations for preparing for current and future hurricane seasons.
This cross-sectional study examines the association between mental health treatment uptake and the existence of state laws prohibiting youths to consent to their own care.
This randomized clinical trial evaluates the effectiveness of pain coping skills training, a cognitive behavioral intervention, on pain interference among people receiving maintenance hemodialysis.
This national survey study assesses the dietary quality of lunch for students participating in the National School Lunch Program (NSLP) before and after implementation of…
This cohort study evaluates the accuracy and efficacy of an artificial intelligence–enabled wearable sensor with closed-loop haptic feedback to decrease nocturnal scratch in patients with…
This cohort study investigates the association between subjective perception of taste loss from early adulthood to mid to late adulthood and all-cause mortality.
This cohort study examines interruption and resumption of endocrine therapy among women with breast cancer who became pregnant.